MwanzoRHHBY • OTCMKTS
Roche Holdings AG Basel ADR Common Stock
$ 39.10
Baada ya Saa za Kazi:
$ 39.10
(0.00%)0.00
Imefungwa: 27 Jan, 16:43:36 GMT -5 · USD · OTCMKTS · Kanusho
Hisa zinazouzwa MarekaniMakao yake makuu ni CH
Bei iliyotangulia
$ 38.05
Bei za siku
$ 38.63 - $ 39.12
Bei za mwaka
$ 29.20 - $ 42.43
Thamani ya kampuni katika soko
254.23B USD
Wastani wa hisa zilizouzwa
1.65M
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(CHF)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Mapato
15.38B0.46%
Matumizi ya uendeshaji wa biashara
6.22B0.75%
Mapato halisi
3.13B-12.32%
Kiwango cha faida halisi
20.35-12.70%
Mapato kwa kila hisa
——
EBITDA
6.17B1.01%
Asilimia ya kodi ya mapato
18.56%—
Jumla ya mali
Jumla ya dhima
(CHF)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
8.81B17.38%
Jumla ya mali
95.79B13.53%
Jumla ya dhima
62.91B16.44%
Jumla ya hisa
32.88B—
hisa zilizosalia
796.79M—
Uwiano wa bei na thamani
1.05—
Faida inayotokana na mali
14.16%—
Faida inayotokana mtaji
19.64%—
Mabadiliko halisi ya pesa taslimu
(CHF)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
3.13B-12.32%
Pesa kutokana na shughuli
3.96B0.20%
Pesa kutokana na uwekezaji
-1.43B-494.40%
Pesa kutokana na ufadhili
-2.72B34.29%
Mabadiliko halisi ya pesa taslimu
-276.00M56.57%
Mtiririko huru wa pesa
3.19B-2.82%
Kuhusu
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. Roche is one of the few companies increasing their dividend every year, for 2020 as the 34th consecutive year. F. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1 Okt 1896
Tovuti
Wafanyakazi
103,605
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu